Legacy App users can now access the Health Portal – just reset your password using email as username.

3 Years Later Off Steroids – 41 y.o. Man’s Case

3 Years Later Off Steroids – 41 y.o. Man’s Case

Member Access Required

Sign in or join the Health Portal to watch this video.

Join Now

Timeline

Timestamp
Topic
00:00
An introduction frames a three year post steroid crash with severe depression and infertility concerns. Identity protection is emphasized while describing a global community of similar cases.
01:28
Chief complaints are summarized, focusing on emotional instability and family disruption after stopping steroids. The reason for stopping is framed around wanting a child and regaining fertility.
02:48
Prior steroid history is reviewed, including intermittent cycles with testosterone and oral compounds. Post cycle therapy is mentioned, yet recovery is described as incomplete and prolonged.
04:10
Baseline medical history is discussed, noting mild lipid issues and otherwise stable general health. Psychiatric evaluations are described as common, yet hormone testing becomes the central focus.
06:01
Total testosterone and free testosterone results are explained using conversions and reference ranges. The case is framed as clearly low, despite earlier clinicians calling it acceptable.
07:40
Discussion shifts to anabolic steroid induced hypogonadism and HPT axis suppression mechanisms. A warning is given that individual thresholds vary, so recovery timelines differ widely.
09:00
Clinical frustration is addressed, emphasizing symptoms over printed ranges and clinician responsibility. Education is encouraged so endocrine causes are not missed in depressed post cycle patients.
10:19
Fertility planning is introduced using gonadotropin strategies rather than immediate testosterone replacement. hCG and HMG roles are explained, with quality concerns about underground products.
11:40
Clomiphene dosing concepts are discussed alongside hCG dosing ranges and monitoring expectations. Patience is emphasized because sperm recovery can take months and timing matters.
13:15
A transition plan is described for later supervised testosterone dosing after fertility goals are achieved. Tradeoffs are reviewed, including infertility recurrence, hair concerns, and ongoing monitoring needs.
14:34
Closing remarks emphasize seeking help early and avoiding shame or stigma for past choices. Long term care is framed around heart risk, blood clots, red blood cells, and quality of life.

Video Summary

A forty one year old man reports three years without anabolic steroids and ongoing suffering. Severe depression is described as disrupting family life, work performance, and daily motivation. The history includes several years of intermittent cycles with testosterone and common oral agents. Post cycle attempts are mentioned, yet symptoms persisted and fertility remained a major concern. Medical evaluations in multiple clinics are described as focusing on psychiatry rather than hormones. The case emphasizes identity protection while still sharing lessons that can help others. A key theme is that stopping steroids does not guarantee rapid endocrine recovery for every person.

Laboratory review highlights total testosterone below two hundred on typical reference ranges. Free testosterone is described as low for age, supporting a clear clinical pattern of deficiency. The pattern is framed as anabolic steroid induced hypogonadism involving hypothalamic pituitary signaling changes. Thyroid testing and complete blood counts are described as normal, limiting alternative explanations. Lifestyle drift is noted, with reduced exercise and poorer nutrition occurring after mood deterioration. Hyperlipidemia is mentioned as a mild risk factor that may worsen when activity drops. The assessment stresses that lab interpretation must match symptoms, not only the printed range.

The first priority is fertility support using gonadotropin based therapy rather than immediate long term testosterone. hCG is described as an LH analog and HMG is described as an FSH analog used together when available. Clomiphene is discussed as an additional tool to stimulate upstream signaling during recovery attempts. A realistic timeline of several months is emphasized because conception depends on cycle timing and sperm recovery. After fertility goals are met, a supervised testosterone plan is discussed at roughly one hundred milligrams every several days. Hair changes are anticipated, so topical minoxidil is suggested while avoiding systemic DHT blocking medicines. Long term monitoring is framed around mood stability, blood counts, clot risk, and cardiovascular health.

Drug Callouts

Drug
Description
Testosterone
Testosterone is an androgen hormone used medically for confirmed symptomatic deficiency. Testosterone appears as a past cycle drug and a later supervised option after fertility goals.
Dianabol
Dianabol is methandrostenolone, an oral anabolic steroid associated with rapid mass gains. Dianabol is listed among compounds used during earlier intermittent cycles in this case.
Anadrol
Anadrol is oxymetholone, an oral anabolic steroid known for strong anabolic effects. Anadrol is mentioned as part of a typical oral steroid menu used before stopping.
Anavar
Anavar is oxandrolone, an oral anabolic steroid often marketed as a milder option. Anavar is included in the described prior cycle history before the long recovery period.
hCG
hCG is human chorionic gonadotropin, a hormone drug that mimics luteinizing hormone activity. hCG is proposed for fertility support and post cycle recovery in the management discussion.
HMG
HMG is human menopausal gonadotropin, a medication containing FSH activity for fertility support. HMG is discussed as helpful yet harder to access and risky from unreliable sources.
Clomiphene
Clomiphene is a selective estrogen receptor modulator that can increase gonadotropin signaling. Clomiphene is recommended as an adjunct alongside hCG during fertility focused recovery.
Minoxidil
Minoxidil is a topical medication used to support hair growth in androgen sensitive hair loss. Minoxidil is suggested as a safer hair strategy while avoiding systemic DHT blocking drugs.

Condition Callouts

Condition
Description
Depression
Depression is a mood disorder marked by persistent low mood and impaired daily function. Depression is described as severe after stopping steroids and affecting family and work.
Infertility
Infertility is reduced ability to conceive due to impaired sperm production or reproductive function. Infertility motivates stopping steroids and drives the fertility first treatment plan.
Anabolic steroid induced hypogonadism
Anabolic steroid induced hypogonadism is low testosterone caused by suppression of the HPT axis after steroid exposure. The diagnosis is named directly and linked to low laboratory testosterone values.
Hyperlipidemia
Hyperlipidemia is abnormal blood lipid levels that increase long term cardiovascular risk. Mild lipid issues are noted and may worsen when exercise decreases during depression.
Erectile dysfunction
Erectile dysfunction is difficulty achieving or maintaining erections adequate for sexual activity. Sexual function is described as poor and contributes to fertility difficulties within the case.
Asthma
Asthma is chronic airway inflammation that causes episodic wheeze and shortness of breath. Asthma is listed in past history and helps frame baseline health before hormone evaluation.
Gastroesophageal reflux disease
Gastroesophageal reflux disease is reflux of stomach contents causing heartburn and irritation. Reflux is mentioned in past history while reviewing medical problems during assessment.
Blood clots
Blood clots are intravascular thrombi that can obstruct circulation and threaten organs. Blood clot risk is mentioned as a monitoring priority when long term hormone management is planned.

Key Takeaways

  • Three years off steroids can still leave severe depression and low testosterone.
  • Anabolic steroid induced hypogonadism is diagnosed using symptoms plus hormone labs.
  • Fertility focused therapy with gonadotropins is prioritized before long term testosterone.
  • Clomiphene and hCG are discussed as tools to support sperm recovery efforts.
  • Long term management must monitor mood, blood counts, clot risk, and heart health.